Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, shared Thomas Ichim’s, President and Chief Scientific Officer at Immorta Bio, shared a post on X:
“So exciting that European clinicians have insights into the immunotherapy approach to address sepsis.
Sepsis affects 50 million people worldwide. Met with the leadership of ImmunoSEP and exchanging information to explore a sepsis trial in Europe.
ALC matters.
IL-15 improves survival as presented in this 2010 paper by Dr. Richard Hotchkiss.”
Title: IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
Authors: Shigeaki Inoue, Jacqueline Unsinger, Christopher G. Davis, Jared T. Muenzer, Thomas A. Ferguson, Katherine Chang, Dale F. Osborne, Andrew T. Clark, Craig M. Coopersmith, Jonathan E. McDunn, Richard S. Hotchkiss
Read the Full Article on The Journal of Immunology
Other posts featuring Patrick Soon-Shiong on OncoDaily.